Literature DB >> 15048651

Regional European differences in allele and genotype frequencies of low density lipoprotein receptor-related protein 1 polymorphism in Alzheimer's disease.

Francesco Panza1, Alessia D'Introno, Anna M Colacicco, Cristiano Capurso, Anna M Basile, Sabrina Capurso, Antonio Capurso, Vincenzo Solfrizzi.   

Abstract

The low density lipoprotein receptor-related protein 1 (LRP1 gene) is a candidate gene for Alzheimer's disease (AD), because it is a ligand for proteins involved in AD pathogenesis, such as apolipoprotein E (APOE), alpha2-macroglobulin (A2M), amyloid precursor protein (APP), and is located on chromosome 12, within a region linked with AD. An association between a silent polymorphism (C/T) in exon 3 and late onset AD has been reported, with an increased frequency of the C allele, although with conflicting results. We examined this polymorphism in a cohort of 166 sporadic AD patients and 225 sex- and age-matched nondemented controls from Southern Italy. No statistically significant differences were found in LRP1 genotype and allele frequencies between the whole AD sample and controls, nor in early- and late-onset subsets of AD patients. No statistically significant differences in frequencies between LRP1 alleles and AD among APOE allele, age, or gender strata were found. Finally, comparing our results with the findings from other European populations, the LRP1 C allele frequency showed a statistically significant decreasing trend from Northern to Southern regions of Europe, with a concomitant increase in LRP1 T allele frequency, but in AD patients only. Finally, in the AD sample, a decreasing geographical trend from North to South of Europe was found for LRP1 CC genotype, and an inverse trend for LRP1 CT genotype frequency. We suggest that these regional variations in LRP1 genotype and allele frequencies in AD could be related to the different patterns of association between this polymorphism and the disease in various European studies. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048651     DOI: 10.1002/ajmg.b.20146

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  5 in total

1.  Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer's disease in a sample of Colombian patients.

Authors:  D A Forero; G Arboleda; J J Yunis; R Pardo; H Arboleda
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

2.  Rates of Cognitive Decline in 100 Patients With Alzheimer Disease.

Authors:  Monica Miyakawa-Liu; Amy K Feehan; Shannon Pai; Julia Garcia-Diaz
Journal:  Ochsner J       Date:  2022

3.  Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.

Authors:  Inês Esteves Baldeiras; Maria Helena Ribeiro; Paula Pacheco; Alvaro Machado; Isabel Santana; Luís Cunha; Catarina Resende Oliveira
Journal:  J Neurol       Date:  2009-05-06       Impact factor: 4.849

4.  Association between LRP1 C766T polymorphism and Alzheimer's disease susceptibility: a meta-analysis.

Authors:  Yun Wang; Shengyuan Liu; Jingjing Wang; Jie Zhang; Yaqiong Hua; Hua Li; Huibiao Tan; Bin Kuai; Biao Wang; Sitong Sheng
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

5.  The LRP1 Gene Polymorphism is associated with Increased Risk of Metabolic Syndrome Prevalence in the Serbian Population.

Authors:  N Vučinić; E Stokić; I Djan; D Obreht; N Veličković; K Stankov; M Djan
Journal:  Balkan J Med Genet       Date:  2017-06-30       Impact factor: 0.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.